Labcorp Holdings
LH • NYSE
Labcorp Holdings is a medical - diagnostics & research company in the healthcare sector trading on NYSE, led by CEO Adam H. Schechter, with a market cap of $22.5B.
CEOAdam H. Schechter
Market Cap$22.5B
Medical - Diagnostics & Research
Healthcare
Employees67.0K
Websitelabcorp.com
Country
United States of America
Next Earnings
Upcoming earnings announcement for Labcorp Holdings
Date
Tuesday, April 28, 2026 (in 2 months)
Timing
Before Market Open (6:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
$4.10
Revenue Estimate
$3.5B
Earnings History
Past 12 earnings reports for Labcorp Holdings
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 17, 2026 | Q4 2025 | $4.07Est: $3.95 | +3.0% | $3.5BEst: $3.6B | -1.1% |  10-K |
| Oct 28, 2025 | Q3 2025 | $4.18Est: $4.13 | +1.2% | $3.6BEst: $3.6B | +0.1% | 10-Q |
| Jul 24, 2025 | Q2 2025 | $4.35Est: $4.15 | +4.8% | $3.5BEst: $3.5B | +1.2% | 10-Q |
| Apr 29, 2025 | Q1 2025 | $3.84Est: $4.17 | -7.9% | $3.3BEst: $3.5B | -3.9% | 10-Q |
| Feb 6, 2025 | Q4 2024 | $3.45Est: $3.39 | +1.8% | $3.3BEst: $3.3B | +0.6% | 10-K |
| Oct 24, 2024 | Q3 2024 | $3.50Est: $3.49 | +0.3% | $3.3BEst: $3.3B | +0.7% | 10-Q |
| Aug 1, 2024 | Q2 2024 | $3.94Est: $3.78 | +4.2% | $3.2BEst: $3.2B | +1.0% | 10-Q |
| Apr 25, 2024 | Q1 2024 | $3.68Est: $3.48 | +5.7% | $3.2BEst: $3.1B | +1.8% | 10-Q |
| Feb 15, 2024 | Q4 2023 | $3.30Est: $3.28 | +0.6% | $3.0BEst: $3.0B | +0.8% | 10-K |
| Oct 26, 2023 | Q3 2023 | $3.38Est: $3.32 | +1.8% | $3.1BEst: $3.0B | +2.2% | 10-Q |
| Jul 27, 2023 | Q2 2023 | $3.42Est: $3.47 | -1.4% | $3.0BEst: $3.0B | +0.8% | — |
| Apr 25, 2023 | Q1 2023 | $3.82Est: $3.96 | -3.5% | $3.8BEst: $3.7B | +2.4% | — |